Stockreport

argenx Reports Full Year 2024 Financial Results and Provides Fourth Quarter Business Update

argenx SE - American Depositary Shares  (ARGX) 
PDF $737 million in fourth quarter and $2.2 billion in full year global product net sales Received positive CHMP recommendation for VYVGART pre-filled syringe for gMG, enab [Read more]